DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,116,000 | -26.6% | 55,337 | +35.8% | 0.00% | 0.0% |
| Q2 2021 | $1,521,000 | -19.7% | 40,753 | -44.9% | 0.00% | -50.0% |
| Q1 2021 | $1,893,000 | +57.2% | 74,018 | +35.4% | 0.00% | +100.0% |
| Q4 2020 | $1,204,000 | +18.3% | 54,666 | -3.4% | 0.00% | 0.0% |
| Q3 2020 | $1,018,000 | -20.3% | 56,584 | +12.6% | 0.00% | -50.0% |
| Q2 2020 | $1,277,000 | -30.4% | 50,274 | -49.7% | 0.00% | 0.0% |
| Q1 2020 | $1,836,000 | +694.8% | 99,896 | +851.3% | 0.00% | – |
| Q4 2019 | $231,000 | +72.4% | 10,501 | +12.3% | 0.00% | – |
| Q3 2019 | $134,000 | – | 9,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |